Article(id=1322906946872943440, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887411688919265, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1626364800000, acceptedDateStr=2021-07-16, onlineDate=1793335194557, onlineDateStr=2026-10-30, pubDate=1636905600000, pubDateStr=2021-11-15, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793335194557, onlineIssueDateStr=2026-10-30, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793335194557, creator=13701087609, updateTime=1793335194557, updator=13701087609, issue=Issue{id=1322887411688919265, tenantId=1146029695717560320, journalId=1235980733773295621, year='2021', volume='30', issue='21', pageStart='1921', pageEnd='2016', issueExtLink='null', onlineDate='null', pubDate='1636905600000', pubDateStr='2021-11-15', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793330537006, creator='13701087609', updateTime=1793337443794, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322916380919608076, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887411688919265, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322916380919608077, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887411688919265, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=2009, endPage=2016, ext={EN=ArticleExt(id=1322906948701659985, articleId=1322906946872943440, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=Mini health technology assessment of four antiangiogenic agents for advanced NSCLC, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=
Objective: To provide a basis for drug selection, as well as safe and rational use of drugs, Mini health technology assessment was used for 4 antiangiogenic agents for the treatment of advanced NSCLC (bevacizumab, ramucirumab, anlotinib, recombinant human endostatin).
Methods: Mini health technology assessment was conducted for the 4 mentioned antiangiogenic agents based on ten aspects, such as pharmaceutical characteristics, effectiveness, safety, economy, medical insurance, national essential drug, storage conditions, expiration date, global use and corporate credibility.
Results: Based on the above evaluation criteria, the scores of the four antiangiogenic agents ranged 61~72. The difference in scores was mainly in terms of effectiveness, safety, economy, and storage conditions. Arotinib scored high in the treatment of small cell lung cancer, and was recommended in the drug selection list of medical institutions.
Conclusion: Mini health technology assessment is a multi-dimensional evaluation of drugs, providing basis for hospital drug selection, safe and rational use. It is of relatively high promotion value.
, authors=Bing-nan REN, Chao-jun XUE, Xiao LI, Yue ZHAO, Zhan-jun DONG, authorsList=Bing-nan REN, Chao-jun XUE, Xiao LI, Yue ZHAO, Zhan-jun DONG, authorCompany=null, correspAuthors=Zhan-jun DONG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322906948991066962, articleId=1322906946872943440, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=4种治疗晚期非小细胞肺癌的抗血管生成药物Mini卫生技术评估, columnId=1236331163573342670, journalTitle=中国新药杂志, columnName=药物安全与合理应用, runingTitle=null, highlight=null, articleAbstract=
目的： 通过对贝伐珠单抗、雷莫芦单抗、安罗替尼、重组人血管内皮抑制素4种治疗晚期非小细胞肺癌（NSCLC）的抗血管生成药进行Mini卫生技术评估，以期为医疗机构药品遴选、药品安全合理使用提供依据。
方法： 从药学特性、有效性、安全性、经济性、医保、国家基本药物、贮藏条件、有效期、全球使用情况和企业信誉度共10个方面对4种抗血管生成药进行Mini卫生技术评估。
结果： 基于上述评估标准，4种抗血管生成药的评分在61~72分，评分差异主要在有效性、安全性、经济性、贮藏条件4个方面。安罗替尼在非小细胞肺癌治疗方面得分较高，受到推荐进入医疗机构药品遴选目录。
结论： Mini卫生技术评估从多个纬度对药品价值进行综合评价，能为医院药品遴选、安全合理使用提供依据，有一定的推广价值。
, authors=任炳楠, 薛朝军, 李宵, 赵越, 董占军, authorsList=任炳楠, 薛朝军, 李宵, 赵越, 董占军, authorCompany=null, correspAuthors=董占军, authorNote=
, correspAuthorsNote=
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=P2fvNNQIntvoIP3xuDwbDg==, magXml=4o4xPZJtah7we5xd0cwNJw==, pdfUrl=null, pdf=EWnS66pb405h/+pMdIKmaQ==, pdfFileSize=1057641, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=LlosyAKm1Y9VyejrkDD15A==, mapNumber=null, fund=null)}, authors=[Author(id=1322906949355971415, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=renbingnanr6@126.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906949452440409, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, authorId=1322906949355971415, language=EN, stringName=Bing-nan REN, firstName=Bing-nan, middleName=null, lastName=REN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906949527937882, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, authorId=1322906949355971415, language=CN, stringName=任炳楠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北省人民医院药学部，石家庄 050000, bio={"content":"
任炳楠，男，硕士，主要从事医院管理研究。E-mail：renbingnanr6@126.com。
"}, bioImg=null, bioContent=
任炳楠，男，硕士，主要从事医院管理研究。E-mail：renbingnanr6@126.com。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906949263696723, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, xref=null, ext=[AuthorCompanyExt(id=1322906949272085332, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China), AuthorCompanyExt(id=1322906949280473941, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北省人民医院药学部，石家庄 050000)])]), Author(id=1322906949599241052, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906949687321438, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, authorId=1322906949599241052, language=EN, stringName=Chao-jun XUE, firstName=Chao-jun, middleName=null, lastName=XUE, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906949771207519, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, authorId=1322906949599241052, language=CN, stringName=薛朝军, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北省人民医院药学部，石家庄 050000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906949263696723, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, xref=null, ext=[AuthorCompanyExt(id=1322906949272085332, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China), AuthorCompanyExt(id=1322906949280473941, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北省人民医院药学部，石家庄 050000)])]), Author(id=1322906949846704993, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906950010282851, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, authorId=1322906949846704993, language=EN, stringName=Xiao LI, firstName=Xiao, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906950081586020, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, authorId=1322906949846704993, language=CN, stringName=李宵, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北省人民医院药学部，石家庄 050000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906949263696723, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, xref=null, ext=[AuthorCompanyExt(id=1322906949272085332, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China), AuthorCompanyExt(id=1322906949280473941, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北省人民医院药学部，石家庄 050000)])]), Author(id=1322906950152889190, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906950236775272, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, authorId=1322906950152889190, language=EN, stringName=Yue ZHAO, firstName=Yue, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906950320661353, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, authorId=1322906950152889190, language=CN, stringName=赵越, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北省人民医院药学部，石家庄 050000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906949263696723, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, xref=null, ext=[AuthorCompanyExt(id=1322906949272085332, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China), AuthorCompanyExt(id=1322906949280473941, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北省人民医院药学部，石家庄 050000)])]), Author(id=1322906950379381611, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=13313213656@126.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322906950467461997, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, authorId=1322906950379381611, language=EN, stringName=Zhan-jun DONG, firstName=Zhan-jun, middleName=null, lastName=DONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906950538765166, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, authorId=1322906950379381611, language=CN, stringName=董占军, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=河北省人民医院药学部，石家庄 050000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906949263696723, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, xref=null, ext=[AuthorCompanyExt(id=1322906949272085332, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China), AuthorCompanyExt(id=1322906949280473941, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北省人民医院药学部，石家庄 050000)])])], keywords=[Keyword(id=1322906950652011375, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=EN, orderNo=1, keyword=non-small cell lung cancer (NSCLC)), Keyword(id=1322906950735897456, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=EN, orderNo=2, keyword=bevacizumab), Keyword(id=1322906950803006321, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=EN, orderNo=3, keyword=ramucirumab), Keyword(id=1322906950874309490, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=EN, orderNo=4, keyword=anlotinib), Keyword(id=1322906950937224051, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=EN, orderNo=5, keyword=recombinant human endostatin), Keyword(id=1322906951000138612, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=EN, orderNo=6, keyword=Mini health technology assessment), Keyword(id=1322906951071441781, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=CN, orderNo=1, keyword=非小细胞肺癌), Keyword(id=1322906951146939254, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=CN, orderNo=2, keyword=贝伐珠单抗), Keyword(id=1322906951218242423, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=CN, orderNo=3, keyword=雷莫芦单抗), Keyword(id=1322906951281156984, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=CN, orderNo=4, keyword=安罗替尼), Keyword(id=1322906951327294329, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=CN, orderNo=5, keyword=重组人血管内皮抑制素), Keyword(id=1322906953013404538, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, language=CN, orderNo=6, keyword=Mini卫生技术评估)], refs=[Reference(id=1322906953122456443, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=CHALKIDOU K, MARTEN R, CUTLER D,
et al. Health technology assessment in universal health coverage[J].
Lancet, 2013, 382(9910): e48-e49., articleTitle=null, refAbstract=null), Reference(id=1322906953193759612, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=邱博, 杨浩天, 宋浩静. 医院卫生技术评估在大环内酯类抗菌药物遴选评价中的应用[J]. 中国现代应用药学, 2021, 38(10): 1228-1236., articleTitle=null, refAbstract=null), Reference(id=1322906953252479869, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=EHLERS L, VESTERGAARD M, KIDHOLM K,
et al. Doing mini-health technology assessments in hospitals: a new concept of decision support in health care?[J].
Int J Technol Assess Health Care, 2006, 22(3): 295-301., articleTitle=null, refAbstract=null), Reference(id=1322906953311200126, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=GRENON X, PINGET C, WASSERFALLEN JB. Hospital-based health technology assessment (hb-hta): a 10-year survey at one unit[J].
Int J Technol Assess Health Care, 2016, 32(3): 116-121., articleTitle=null, refAbstract=null), Reference(id=1322906953378308991, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=HERBST RS, ONN A, SANDLER A. Angiogenesis and lung cancer: prognostic and therapeutic implications[J].
J Clin Oncol, 2005, 23(14): 3243-3256., articleTitle=null, refAbstract=null), Reference(id=1322906953441223552, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=HANSMA AH, BROXTERMAN HJ, VAN DER HORST I,
et al. Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer[J].
Ann Oncol, 2005, 16(10): 1695-1701., articleTitle=null, refAbstract=null), Reference(id=1322906953504138113, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=ROVIELLO G, BACHELOT T, HUDIS CA,
et al. The role of bevacizumab in solid tumours: a literature based meta-analysis of randomised trials[J].
Eur J Cancer, 2017, 75: 245-258., articleTitle=null, refAbstract=null), Reference(id=1322906953567052674, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=SAITO H, FUKUHARA T, FURUYA N,
et al. Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial[J].
Lancet Oncol, 2019, 20(5): 625-635., articleTitle=null, refAbstract=null), Reference(id=1322906953646744451, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=TEWARI KS, SILL MW, PENSON RT,
et al. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)[J].
Lancet, 2017, 390(10103): 1654-1663., articleTitle=null, refAbstract=null), Reference(id=1322906953718047620, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=RINI BI, POWLES T, ATKINS MB,
et al. Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial[J].
Lancet, 2019, 393(10189): 2404-2415., articleTitle=null, refAbstract=null), Reference(id=1322906953789350789, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=TOMASELLO G, PETRELLI F, GHIDINI M,
et al. FOLFOXIRI plus bevacizumab as conversion therapy for patients with initially unresectable metastatic colorectal cancer: a systematic review and pooled analysis[J].
JAMA Oncol, 2017, 3(7): e170278., articleTitle=null, refAbstract=null), Reference(id=1322906953852265350, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=GARON EB, CIULEANU TE, ARRIETA O,
et al. Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial[J].
Lancet, 2014, 384(9944): 665-673., articleTitle=null, refAbstract=null), Reference(id=1322906953936151431, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=RECK M, PAZ-ARES L, BIDOLI P,
et al. Outcomes in patients with aggressive or refractory disease from REVEL: a randomized phase Ⅲ study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer[J].
Lung Cancer, 2017, 112: 181-187., articleTitle=null, refAbstract=null), Reference(id=1322906954003260296, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=HAN B, LI K, WANG Q,
et al. Effect of anlotinib as a third-line or further treatment on overall survival of patients with advanced non-small cell lung cancer: the ALTER 0303 phase 3 randomized clinical trial[J].
JAMA Oncol, 2018, 4(11): 1569-1575., articleTitle=null, refAbstract=null), Reference(id=1322906954082952073, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=AN J, LV W. Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: a meta-analysis[J].
Thorac Cancer, 2018, 9(5): 606-612., articleTitle=null, refAbstract=null), Reference(id=1322906954158449546, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=MA Z, GUO LF, CUI XL,
et al. Rh-endostatin concomitant with chemotherapy versus single agent chemotherapy for treating soft tissue and bone sarcomas: a systematic review and meta-analysis[J].
J Pharm Pharm Sci, 2018, 21(1): 386-397., articleTitle=null, refAbstract=null), Reference(id=1322906954242335627, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=LI M, KROETZ DL. Bevacizumab-induced hypertension: Clinical presentation and molecular understanding[J].
Pharmacol Ther, 2018, 182: 152-160., articleTitle=null, refAbstract=null), Reference(id=1322906954334610316, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=BRANDES AA, BARTOLOTTI M, TOSONI A,
et al. Practical management of bevacizumab-related toxicities in glioblastoma[J].
Oncologist, 2015, 20(2): 166-175., articleTitle=null, refAbstract=null), Reference(id=1322906954401719181, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN J, LU Y, ZHENG Y. Incidence and risk of hypertension with bevacizumab in non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials[J].
Drug Des Devel Ther, 2015, 9: 4751-4760., articleTitle=null, refAbstract=null), Reference(id=1322906954460439438, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=SHAH SR, GRESSETT USSERY SM, DOWELL JE,
et al. Shorter bevacizumab infusions do not increase the incidence of proteinuria and hypertension[J].
Ann Oncol, 2013, 24(4): 960-965., articleTitle=null, refAbstract=null), Reference(id=1322906954523353999, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG L, CHEN CJ, GUO XL,
et al. Bevacizumab and risk of intracranial hemorrhage in patients with brain metastases: a meta-analysis[J].
J Neurooncol, 2018, 137(1): 49-56., articleTitle=null, refAbstract=null), Reference(id=1322906954598851472, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=WOZNIAK AJ, KOSTY MP, JAHANZEB M,
et al. Clinical outcomes in elderly patients with advanced non-small cell lung cancer: results from ARIES, a bevacizumab observational cohort study[J].
Clin Oncol (R Coll Radiol), 2015, 27(4): 187-196., articleTitle=null, refAbstract=null), Reference(id=1322906954657571729, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=MILLAN NC, POVEDA MJ, CRUZ O,
et al. Safety of bevacizumab in patients younger than 4 years of age[J].
Clin Transl Oncol, 2016, 18(5): 464-468., articleTitle=null, refAbstract=null), Reference(id=1322906954720486290, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=ARNOLD D, FUCHS CS, TABERNERO J,
et al. Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab[J].
Ann Oncol, 2017, 28(12): 2932-2942., articleTitle=null, refAbstract=null), Reference(id=1322906954795983763, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=SUN Y, WANG JW, LIU YY,
et al. Long-term results of a randomized, double-blind, and placebo-controlled phase Ⅲ trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancer[J].
Thorac Cancer, 2013, 4(4): 440-448., articleTitle=null, refAbstract=null), Reference(id=1322906954875675540, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=GOLDSTEIN DA, EL-RAYES BF. Considering efficacy and cost, where does ramucirumab fit in the management of metastatic colorectal cancer?[J].
Oncologist, 2015, 20(9): 981-982., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1322906949263696723, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, xref=null, ext=[AuthorCompanyExt(id=1322906949272085332, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pharmacy, Hebei General Hospital, Shijiazhuang 050000, China), AuthorCompanyExt(id=1322906949280473941, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906946872943440, companyId=1322906949263696723, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=河北省人民医院药学部，石家庄 050000)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1788948968376, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509780974924039, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968404, updatedTime=1788948968404, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509781025255688, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968416, updatedTime=1788948968416, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2021/V30/I21/2009, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2021/V30/I21/2009, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2021/V30/I21/2009, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2021/V30/I21/2009, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1636905600000, fullTextJson=null, articleText=null, reference=null)
全屏
文章导航
PDF下载
5
0
关闭全屏
北京市海淀区学院南路86号
010-62662699（运营及技术支持）
qkjq@cast.org.cn
